People · Operator
Named in public records as an officer, director or promoter · active 2023–2024 · Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Akadeum Life Sciences, Inc. | — | Other Health Care | Series A | $15.4M | $20.5M | 2023 |
| SimBioSys, Inc. | — | Biotechnology | Series A | $6.1M | $22.0M | 2024 |
William Hyun at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside William Hyun on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Paul Brown | 1 | 12 |
| William Wood | 1 | 9 |
| George Dunbar | 1 | 5 |
| Paul D'Amato | 1 | 4 |
| Dan Kidle | 1 | 4 |
| Jeffrey S. Williams | 1 | 2 |
| Brock Siegel | 1 | 2 |
| Lucy Coassin | 1 | 2 |
| Vikram Chaudhery | 1 | 2 |
| Ronnie Andrews | 1 | 2 |
| Joseph Peterson | 1 | 2 |
| Stacey Stevens | 1 | 2 |
| Joseph R Peterson | 1 | 1 |
| John A Cole | 1 | 1 |
| Douglas Neal | 1 | 1 |
| Brandon McNaughton | 1 | 1 |
| John Younger | 1 | 1 |
| James S. Militello | 1 | 1 |
| John Gavenonis | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.